Skip to main content

Advertisement

Log in

Obstructive Sleep Apnea and Smoking as a Risk Factor for Venous Thromboembolism Events: Review of the Literature on the Common Pathophysiological Mechanisms

  • Review Article
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Venous thromboembolism events (VTE) are a common and preventable cause of postoperative complications. Interestingly, smoking and obstructive sleep apnea syndrome (OSA) affecting a large part of our population (and especially obese patients) are two underestimated predisposing factors of VTE. Many coagulation disorders favoring thromboembolism have been identified in the case of OSA and smoking and are reviewed in this article. They can be divided into two entities: endothelial dysfunction and hemostasis disorders. Interestingly OSA and smoking share common pathways to the prothrombotic state. The interactions with others comorbidities will also be discussed. This article provides pathophysiological mechanisms of the increased risk of thromboembolism in OSA patients and smokers, which should help manage these patients more adequately during the perioperative period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e227S–77.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients. Chest. 2012;141:e278S–325.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e195S–226.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:136–43.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Garvey JF, Pengo MF, Drakatos P, et al. Epidemiological aspects of obstructive sleep apnea. J Thorac Dis. 2015;7:920–9.

    PubMed Central  PubMed  Google Scholar 

  6. Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014;383:736–47.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Bosanquet JP, Bade BC, Zia MF, et al. Patients with venous thromboembolism appear to have higher prevalence of obstructive sleep apnea than the general population. Clin Appl Thromb Hemost. 2011;17:E119–24.

    Article  PubMed  Google Scholar 

  8. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979–1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163:1711–7.

    Article  PubMed  Google Scholar 

  9. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e278S–325.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43:1731–7.

    Article  CAS  PubMed  Google Scholar 

  11. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315:973–80.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Cheng YJ, Liu ZH, Yao FJ, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med. 2013;10:e1001515.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Budhiraja R, Parthasarathy S, Quan SF. Endothelial dysfunction in obstructive sleep apnea. J Clin Sleep Med. 2007;3:409–15.

    PubMed Central  PubMed  Google Scholar 

  14. Aird WC. Endothelial cell heterogeneity. Crit Care Med. 2003;31:S221–30.

    Article  PubMed  Google Scholar 

  15. Nieto FJ, Herrington DM, Redline S, et al. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med. 2004;169:354–60.

    Article  PubMed  Google Scholar 

  16. Korcarz CE, Gepner AD, Peppard PE, et al. The effects of sleep-disordered breathing on arterial stiffness are modulated by age. Sleep. 2010;33:1081–5.

    PubMed Central  PubMed  Google Scholar 

  17. Ip MS, Tse HF, Lam B, et al. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med. 2004;169:348–53.

    Article  PubMed  Google Scholar 

  18. Namtvedt SK, Hisdal J, Randby A, Agewall S, Stranden E, Somers VK, Røsjø H, Omland T. Impaired endothelial function in persons with obstructive sleep apnoea: impact of obesity. Heart. 2012.

  19. Wannamethee SG, Lowe GD, Shaper AG, et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005;26:1765–73.

    Article  CAS  PubMed  Google Scholar 

  20. Blitzer ML, Loh E, Roddy MA, et al. Endothelium-derived nitric oxide regulates systemic and pulmonary vascular resistance during acute hypoxia in humans. J Am Coll Cardiol. 1996;28:591–6.

    Article  CAS  PubMed  Google Scholar 

  21. Lusis AJ. Atherosclerosis. Nature. 2000;407:233–41.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J. 2003;79:195–9. quiz 98–200.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:7–17.

    Article  CAS  PubMed  Google Scholar 

  24. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117:2270–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol. 1996;28:1161–7.

    Article  CAS  PubMed  Google Scholar 

  26. Buchner NJ, Quack I, Woznowski M, et al. Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy. Respiration. 2011;82:409–17.

    Article  PubMed  Google Scholar 

  27. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. CHEST J. 2007;131:1557–66.

    Article  CAS  Google Scholar 

  28. Barua RS, Ambrose JA. Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol. 2013;33:1460–7.

    Article  CAS  PubMed  Google Scholar 

  29. Phillips BG, Hisel TM, Kato M, et al. Recent weight gain in patients with newly diagnosed obstructive sleep apnea. J Hypertens. 1999;17:1297–300.

    Article  CAS  PubMed  Google Scholar 

  30. Rahman MM, Elmi S, Chang TK, et al. Increased vascular contractility in isolated vessels from cigarette smoking rats is mediated by basal endothelin release. Vasc Pharmacol. 2007;46:35–42.

    Article  CAS  Google Scholar 

  31. Moller DS, Lind P, Strunge B, et al. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens. 2003;16:274–80.

    Article  CAS  PubMed  Google Scholar 

  32. Ohga E, Nagase T, Tomita T, et al. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol (Bethesda, Md: 1985). 1999;87:10–4.

    CAS  Google Scholar 

  33. El-Solh AA, Mador MJ, Sikka P, et al. Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest. 2002;121:1541–7.

    Article  CAS  PubMed  Google Scholar 

  34. Mazzone A, Cusa C, Mazzucchelli I, et al. Cigarette smoking and hypertension influence nitric oxide release and plasma levels of adhesion molecules. Clin Chem Lab Med CCLM/FESCC. 2001;39:822–6.

    CAS  Google Scholar 

  35. Adams MR, Jessup W, Celermajer DS. Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol. 1997;29:491–7.

    Article  CAS  PubMed  Google Scholar 

  36. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med. 2002;165:934–9.

    Article  PubMed  Google Scholar 

  37. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J Suppl. 2003;46:5s–13.

    Article  CAS  PubMed  Google Scholar 

  38. Dyugovskaya L, Polyakov A, Lavie P, et al. Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med. 2008;177:544–54.

    Article  CAS  PubMed  Google Scholar 

  39. Luc G, Bard JM, Juhan-Vague I, et al. C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol. 2003;23:1255–61.

    Article  CAS  PubMed  Google Scholar 

  40. Lavie L, Polotsky V. Cardiovascular aspects in obstructive sleep apnea syndrome--molecular issues, hypoxia and cytokine profiles. Respiration. 2009;78:361–70.

    Article  CAS  PubMed  Google Scholar 

  41. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ. 1989;298:784–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  42. Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5:549–55.

    Article  PubMed Central  PubMed  Google Scholar 

  43. Peppard PE, Young T, Palta M, et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA J Am Med Assoc. 2000;284:3015–21.

    Article  CAS  Google Scholar 

  44. Beccuti G, Pannain S. Sleep and obesity. Curr Opin Clin Nutr Metab Care. 2011;14:402–12.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Bouloumie A, Marumo T, Lafontan M, et al. Leptin induces oxidative stress in human endothelial cells. FASEB J Off Publ Fed Am Soc Exp Biol. 1999;13:1231–8.

    CAS  Google Scholar 

  46. Bouloumie A, Drexler HC, Lafontan M, et al. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res. 1998;83:1059–66.

    Article  CAS  PubMed  Google Scholar 

  47. Luo JD, Zhang GS, Chen MS. Leptin and cardiovascular diseases. Drug News Perspect. 2005;18:427–31.

    Article  CAS  PubMed  Google Scholar 

  48. Oda A, Taniguchi T, Yokoyama M. Leptin stimulates rat aortic smooth muscle cell proliferation and migration. Kobe J Med Sci. 2001;47:141–50.

    CAS  PubMed  Google Scholar 

  49. Nishimura M, Izumiya Y, Higuchi A, et al. Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation. 2008;117:216–23.

    Article  CAS  PubMed  Google Scholar 

  50. Zhang XL, Yin KS, Wang H, et al. Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration. 2006;73:73–7.

    Article  PubMed  Google Scholar 

  51. Preckel D, von Kanel R. Regulation of hemostasis by the sympathetic nervous system: any contribution to coronary artery disease? Heartdrug Excell Cardiovasc Trials. 2004;4:123–30.

    Google Scholar 

  52. Marrone O, Riccobono L, Salvaggio A, et al. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest. 1993;103:722–7.

    Article  CAS  PubMed  Google Scholar 

  53. Adamopoulos D, van de Borne P, Argacha JF. New insights into the sympathetic, endothelial and coronary effects of nicotine. Clin Exp Pharmacol Physiol. 2008;35:458–63.

    Article  CAS  PubMed  Google Scholar 

  54. Millar PJ, Murai H, Floras JS. Neurogenic retrograde arterial flow during obstructive sleep apnea: a novel mechanism for endothelial dysfunction? Hypertension. 2011.

  55. Riha RL, Brander P, Vennelle M, et al. Tumour necrosis factor-alpha (−308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J. 2005;26:673–8.

    Article  CAS  PubMed  Google Scholar 

  56. Lin L, Finn L, Zhang J, et al. Angiotensin-converting enzyme, sleep-disordered breathing, and hypertension. Am J Respir Crit Care Med. 2004;170:1349–53.

    Article  PubMed  Google Scholar 

  57. Wang XL, Sim AS, Wang MX, et al. Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett. 2000;471:45–50.

    Article  CAS  PubMed  Google Scholar 

  58. Wang XL, Greco M, Sim AS, et al. Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes. Atherosclerosis. 2002;162:391–7.

    Article  CAS  PubMed  Google Scholar 

  59. Wang XL, Raveendran M, Wang J. Genetic influence on cigarette-induced cardiovascular disease. Prog Cardiovasc Dis. 2003;45:361–82.

    Article  CAS  PubMed  Google Scholar 

  60. Bokinsky G, Miller M, Ault K, et al. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest. 1995;108:625–30.

    Article  CAS  PubMed  Google Scholar 

  61. Fusegawa Y, Goto S, Handa S, et al. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res. 1999;93:271–8.

    Article  CAS  PubMed  Google Scholar 

  62. Takajo Y, Ikeda H, Haramaki N, et al. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet aggregability. J Am Coll Cardiol. 2001;38:1320–7.

    Article  CAS  PubMed  Google Scholar 

  63. Freedman JE. Molecular regulation of platelet-dependent thrombosis. Circulation. 2005;112:2725–34.

    Article  PubMed  Google Scholar 

  64. Sambola A, Osende J, Hathcock J, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003;107:973–7.

    Article  CAS  PubMed  Google Scholar 

  65. El Solh AA, Akinnusi ME, Berim IG, et al. Hemostatic implications of endothelial cell apoptosis in obstructive sleep apnea. Sleep Breath. 2008;12:331–7.

    Article  PubMed  Google Scholar 

  66. Barua RS, Ambrose JA, Saha DC, et al. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration. Circulation. 2002;106:905–8.

    Article  PubMed  Google Scholar 

  67. Dotevall A, Johansson S, Wilhelmsen L. Association between fibrinogen and other risk factors for cardiovascular disease in men and women. Results from the Goteborg MONICA survey 1985. Ann Epidemiol. 1994;4:369–74.

    Article  CAS  PubMed  Google Scholar 

  68. Wessendorf TE, Thilmann AF, Wang YM, et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med. 2000;162:2039–42.

    Article  CAS  PubMed  Google Scholar 

  69. Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996;153:1972–6.

    Article  CAS  PubMed  Google Scholar 

  70. Shitrit D, Peled N, Shitrit AB, et al. An association between oxygen desaturation and D-dimer in patients with obstructive sleep apnea syndrome. Thromb Haemost. 2005;94:544–7.

    CAS  PubMed  Google Scholar 

  71. von Kanel R, Loredo JS, Ancoli-Israel S, et al. Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest. 2007;131:733–9.

    Article  Google Scholar 

  72. Robinson GV, Pepperell JCT, Segal HC, et al. Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax. 2004;59:777–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  73. von Kanel R, Loredo JS, Powell FL, et al. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin Hemorheol Microcirc. 2005;33:369–77.

    Google Scholar 

  74. Barceló A, Piérola J, de la Peña M, et al. Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea. Eur Respir J. 2012;39:913–8.

    Article  PubMed  Google Scholar 

  75. von Kanel R, Loredo JS, Ancoli-Israel S, et al. Association between sleep apnea severity and blood coagulability: treatment effects of nasal continuous positive airway pressure. Sleep Breath. 2006;10:139–46.

    Article  Google Scholar 

  76. Simpson AJ, Gray RS, Moore NR, et al. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br J Haematol. 1997;97:208–13.

    Article  CAS  PubMed  Google Scholar 

  77. Newby DE, Wright RA, Labinjoh C, et al. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation. 1999;99:1411–5.

    Article  CAS  PubMed  Google Scholar 

  78. Lippi G, Mattiuzzi C, Franchini M. Sleep apnea and venous thromboembolism. A systematic review. Thromb Haemost. 2015;114:885–9.

    Article  Google Scholar 

  79. Peng YH, Liao WC, Chung WS, et al. Association between obstructive sleep apnea and deep vein thrombosis / pulmonary embolism: a population-based retrospective cohort study. Thromb Res. 2014;134:340–5.

    Article  CAS  PubMed  Google Scholar 

  80. D’Apuzzo MR, Browne JA. Obstructive sleep apnea as a risk factor for postoperative complications after revision joint arthroplasty. J Arthroplast. 2012;27:95–8.

    Article  Google Scholar 

  81. Sapala JA, Wood MH, Schuhknecht MP, et al. Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg. 2003;13:819–25.

    Article  PubMed  Google Scholar 

  82. Louis JM, Mogos MF, Salemi JL, et al. Obstructive sleep apnea and severe maternal-infant morbidity/mortality in the United States, 1998–2009. Sleep. 2014;37:843–9.

    PubMed Central  PubMed  Google Scholar 

  83. Mraovic B, Hipszer BR, Epstein RH, et al. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplast. 2010;25:64–70.

    Article  Google Scholar 

  84. Memtsoudis S, Liu S, Ma Y, et al. Perioperative pulmonary outcomes in patients with sleep apnea after noncardiac surgery. Anesth Analg. 2011;112:113–21.

    Article  PubMed  Google Scholar 

  85. Hansson PO, Eriksson H, Welin L, et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: “the study of men born in 1913”. Arch Intern Med. 1999;159:1886–90.

    Article  CAS  PubMed  Google Scholar 

  86. Zhang G, Xu X, Su W, et al. Smoking and risk of venous thromboembolism: a systematic review. Southeast Asian J Trop Med Publ Health. 2014;45:736–45.

    Google Scholar 

  87. Hawn MT, Houston TK, Campagna EJ, et al. The attributable risk of smoking on surgical complications. Ann Surg. 2011;254:914–20.

    Article  PubMed  Google Scholar 

  88. Krishnan V, Dixon-Williams S, Thornton JD. Where there is smoke…there is sleep apnea: exploring the relationship between smoking and sleep apnea. Chest. 2014;146:1673–80.

    Article  PubMed Central  PubMed  Google Scholar 

  89. Tzischinsky O, Cohen A, Doveh E, et al. Screening for sleep disordered breathing among applicants for a professional driver’s license. J Occup Environ Med/Am Coll Occup Environ Med. 2012;54:1275–80.

    Article  Google Scholar 

  90. Wetter DW, Young TB, Bidwell TR, et al. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med. 1994;154:2219–24.

    Article  CAS  PubMed  Google Scholar 

  91. Varol Y, Anar C, Tuzel OE, et al. The impact of active and former smoking on the severity of obstructive sleep apnea. Sleep Breath. 2015;19(4):1279–84.

    Article  PubMed  Google Scholar 

  92. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829–36.

    Article  CAS  PubMed  Google Scholar 

  93. Samama CM, Godier A. Perioperative deep vein thrombosis prevention: what works, what does not work and does it improve outcome? Curr Opin Anaesthesiol. 2011;24:166–70.

    Article  PubMed  Google Scholar 

  94. Guyatt GH, Eikelboom JW, Gould MK, et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e185S–94.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  95. Deflandre E, Degey S, Bonhomme V, Donneau AF, Poirrier R, Brichant JF, Hans P. Preoperative adherence to continuous positive airway pressure among obstructive sleep apnea patients. Minerva Anestesiol. 2014.

  96. Deflandre E, Brichant JF, Bonhomme V. Obstructive sleep apnea and detection of non-adherence to CPAP in OSA: limits of the pre-anesthesia visit. Minerva Anestesiol. 2015.

  97. Jiang X, Yongxiang W, Wei Z, et al. Higher dose of warfarin for patients with pulmonary embolism complicated by obstructive sleep apnea hypopnea syndrome. Heart Lung J Crit Care. 2014;43:358–62.

    Article  Google Scholar 

  98. Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2014;3:CD002294.

    PubMed  Google Scholar 

  99. Khullar D, Maa J. The impact of smoking on surgical outcomes. J Am Coll Surg. 2012;215:418–26.

    Article  PubMed  Google Scholar 

  100. Deflandre E, Degey S, Clerdain AM, et al. Perioperative tobacco cessation: a crucial period to overcome clinical inertia and poor compliance. Rev Med Liege. 2010;65:332–7.

    CAS  PubMed  Google Scholar 

  101. Wong J, Lam DP, Abrishami A, et al. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth J Can Anesth. 2012;59:268–79.

    Article  Google Scholar 

  102. Colrain IM, Trinder J, Swan GE. The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2004;6:913–25.

    Article  Google Scholar 

Download references

Acknowledgments

The authors want to acknowledge Damien Kempeneers and Alexander Gerdom for their participations.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric Deflandre.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Ethical Approval

For this type of study, formal consent is not required.

Informed Consent

Does not apply.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deflandre, E., Degey, S., Opsomer, N. et al. Obstructive Sleep Apnea and Smoking as a Risk Factor for Venous Thromboembolism Events: Review of the Literature on the Common Pathophysiological Mechanisms. OBES SURG 26, 640–648 (2016). https://doi.org/10.1007/s11695-015-2012-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-015-2012-0

Keywords

Navigation